Ying-Yang Xu (Yingyang Xu)

Publication Activity (10 Years)

Years Active: 2018-2022
Publications (10 Years): 5

Top Topics

Respiratory Syndrome Coronavirus

Atopic Dermatitis

Top Venues

Journal of asthma and allergy

Clinical and translational allergy

Contact dermatitis

This page only lists publications with an associated author ORCID identifier.

Publications

Ying-Yang Xu, Kai Guan
Real-life data on inactivated COVID-19 vaccination in patients with subcutaneous allergen immunotherapy. Clinical and translational allergy 12 (1) (2022)
Lisha Li, Zixi Wang, Le Cui, Ying-Yang Xu, Kai Guan, Bin Zhao
Anaphylactic risk related to omalizumab, benralizumab, reslizumab, mepolizumab, and dupilumab. Clinical and translational allergy 11 (4) (2021)
Jun-Da Li, Le Cui, Ying-Yang Xu, Kai Guan
A Case of Anaphylaxis Caused by Major Royal Jelly Protein 3 of Royal Jelly and Its Cross-Reactivity with Honeycomb. Journal of asthma and allergy 14 (2021)
Ying-Yang Xu, Kai Guan, Li Sha, Jinghong Zhang, Yongliang Niu, Jia Yin, Lianglu Wang
Sensitization Profiles of Timothy Grass Pollen in Northern China. Journal of asthma and allergy 14 (2021)
Ying-Yang Xu, Li Li, Lei Xuan, Kai Guan
Patch test diagnosis of non-immediate cutaneous reaction to myrrh following oral intake of a traditional Chinese medicine decoction. Contact dermatitis 80 (2) (2018)